Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.07 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.07 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.05 | 0.08 |